ivabradine has been researched along with Graft vs Host Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aizawa, K; Hayasaka, T; Himuro, M; Ichikawa, T; Ishizawa, K; Ito, S; Nakamura, N; Suzuki, H; Toubai, T; Wanezaki, M; Watanabe, M; Yamada, A; Yamamoto, M; Yanagiya, R | 1 |
1 other study(ies) available for ivabradine and Graft vs Host Disease
| Article | Year |
|---|---|
Ivabradine as an Adjuvant Agent for Severe Heart Failure Occurring in the Early Phase after Allogeneic Hematopoietic Cell Transplantation.
Topics: Cardiotoxicity; Graft vs Host Disease; Heart Failure; Hematopoietic Stem Cell Transplantation; Humans; Ivabradine; Transplantation Conditioning; Transplantation, Homologous | 2022 |